AR015976A1 - Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento - Google Patents
Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamentoInfo
- Publication number
- AR015976A1 AR015976A1 ARP980105251A ARP980105251A AR015976A1 AR 015976 A1 AR015976 A1 AR 015976A1 AR P980105251 A ARP980105251 A AR P980105251A AR P980105251 A ARP980105251 A AR P980105251A AR 015976 A1 AR015976 A1 AR 015976A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture
- dry eye
- agonists
- same
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
Abstract
Una composicion para el tratamiento del ojo seco en humanos, que comprende una cantidad farmacéuticamente efectiva de uno o más agonista(s) de H2 dehistamina tales como dimaprit, anthamine e impromidine, en un portador farmacéuticamente aceptable; yel uso de la misma para la manufactura de unmedicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6290697P | 1997-10-21 | 1997-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015976A1 true AR015976A1 (es) | 2001-05-30 |
Family
ID=22045617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105251A AR015976A1 (es) | 1997-10-21 | 1998-10-21 | Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento |
Country Status (5)
Country | Link |
---|---|
US (1) | US6274160B1 (es) |
AR (1) | AR015976A1 (es) |
AU (1) | AU1104799A (es) |
WO (1) | WO1999020265A1 (es) |
ZA (1) | ZA989513B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5663025B2 (ja) | 2009-09-15 | 2015-02-04 | キューエルティー インコーポレイテッド | 9−cis−レチニルエステルを脂質ビヒクル中に含む医薬製剤 |
RU2622763C2 (ru) | 2010-04-19 | 2017-06-19 | Новелион Терапьютикс Инк. | Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов |
WO2013134867A1 (en) | 2012-03-01 | 2013-09-19 | Qlt Inc. | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991759A (en) | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4370325A (en) | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
US4315024A (en) * | 1980-08-08 | 1982-02-09 | Cooper Laboratories, Inc. | Compositions and method for treating red eye |
US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4744980A (en) | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
US4966773A (en) | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
ATE132366T1 (de) | 1990-05-29 | 1996-01-15 | Boston Ocular Res | Zusammensetzung zur behandlung von dry eye erkrankungen |
ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
US5290572A (en) | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
BR9203277A (pt) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao |
US5869479A (en) * | 1997-08-14 | 1999-02-09 | Schering Corporation | Treatment of upper airway allergic responses |
-
1998
- 1998-10-19 ZA ZA989513A patent/ZA989513B/xx unknown
- 1998-10-20 AU AU11047/99A patent/AU1104799A/en not_active Abandoned
- 1998-10-20 US US09/529,837 patent/US6274160B1/en not_active Expired - Fee Related
- 1998-10-20 WO PCT/US1998/022144 patent/WO1999020265A1/en active Application Filing
- 1998-10-21 AR ARP980105251A patent/AR015976A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU1104799A (en) | 1999-05-10 |
US6274160B1 (en) | 2001-08-14 |
WO1999020265A1 (en) | 1999-04-29 |
ZA989513B (en) | 1999-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008001920A1 (es) | Composicion farmaceutica que comprende un inhibidor de la pde 2, un agonista del receptor selectivo e2 y un portador; y uso en el tratamiento de fractura y/o defecto oseo (div. sol. 3179-04). | |
YU38802A (sh) | Nova kompozicija i njena upotreba | |
MD960330A (ro) | Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament | |
AP2002002458A0 (en) | Compounds for the treatment of ischemia. | |
AR066982A2 (es) | Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos | |
AR010385A1 (es) | Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto. | |
HUP0103567A2 (hu) | ORL-1 receptor agonistaként alkalmazható 2-helyzetben helyettesített 1-piperidil-benzimidazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények | |
AU2855399A (en) | Vascularization inhibitors | |
IE873125L (en) | Benzimidazole derivatives | |
ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
IL139318A0 (en) | Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same | |
AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
CL2002001701A1 (es) | Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno. | |
SV2008002856A (es) | 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas | |
AR015976A1 (es) | Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento | |
MX210235B (es) | Oxiranil-triazolintionas y su empleo como microbicidas | |
HRP20000781B1 (en) | Effervescent preparations | |
ES2191908T3 (es) | 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido. | |
ES2193007T1 (es) | Formulacion farmaceutica estable que comprende la modificacion ii de torsemida. | |
BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
AR008154A1 (es) | Acido (s)-7-[(4,4'-bipiperidin-1-il)carbonil]-2,3,4,5-tetrahidro-4-metil- -3-oxo-1h-1,4-benzodiazepina-2-acetico, como hidrocloruro del mismo, unacomposicion farmaceutica que lo comprende, el uso del mismo y un procedimiento para su preparacion. | |
ES2084738T3 (es) | Una almohadilla absorbente, un procedimiento para la obtencion de una almohadilla absorbente, y un articulo absorbente desechable. | |
ATE147742T1 (de) | 8-alpha-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel | |
ES2183205T3 (es) | Hcg y derivados en calidad de inhibidores de melaloproteasas de la matriz. |